Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 141

    1.

    Effects of menstrual cycle status and gender on human neutrophil phenotype.

    Smith JM, Shen Z, Wira CR, Fanger MW, Shen L.

    Am J Reprod Immunol. 2007 Aug;58(2):111-9.PMID: 17631004 [PubMed - indexed for MEDLINE]Related articles

    2.

    Human fallopian tube neutrophils--a distinct phenotype from blood neutrophils.

    Smith JM, Wira CR, Fanger MW, Shen L.

    Am J Reprod Immunol. 2006 Oct;56(4):218-29.PMID: 16938110 [PubMed - indexed for MEDLINE]Related articles

    3.

    Differential regulation of neutrophil chemotaxis to IL-8 and fMLP by GM-CSF: lack of direct effect of oestradiol.

    Shen L, Smith JM, Shen Z, Hussey SB, Wira CR, Fanger MW.

    Immunology. 2006 Feb;117(2):205-12.PMID: 16423056 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Bispecific antibodies for the treatment of tumours and infectious diseases.

    Drakeman DL, Fanger MW, Wallace PK.

    Expert Opin Investig Drugs. 1997 Sep;6(9):1169-78.PMID: 15991891 [PubMed]Related articles

    5.

    Mannose receptor-targeted vaccines.

    Keler T, Ramakrishna V, Fanger MW.

    Expert Opin Biol Ther. 2004 Dec;4(12):1953-62. Review.PMID: 15571457 [PubMed - indexed for MEDLINE]Related articles

    6.

    Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I.

    Yeaman GR, Asin S, Weldon S, Demian DJ, Collins JE, Gonzalez JL, Wira CR, Fanger MW, Howell AL.

    Immunology. 2004 Dec;113(4):524-33.PMID: 15554931 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Synergy between IL-8 and GM-CSF in reproductive tract epithelial cell secretions promotes enhanced neutrophil chemotaxis.

    Shen L, Fahey JV, Hussey SB, Asin SN, Wira CR, Fanger MW.

    Cell Immunol. 2004 Jul;230(1):23-32.PMID: 15541716 [PubMed - indexed for MEDLINE]Related articles

    8.

    Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts.

    Asin SN, Fanger MW, Wildt-Perinic D, Ware PL, Wira CR, Howell AL.

    J Infect Dis. 2004 Jul 15;190(2):236-45. Epub 2004 Jun 11.PMID: 15216456 [PubMed - indexed for MEDLINE]Related articles

    9.

    Inhibition of human polymorphonuclear cell oxidative burst by 17-beta-estradiol and 2,3,7,8-tetrachlorodibenzo-p-dioxin.

    Abrahams VM, Collins JE, Wira CR, Fanger MW, Yeaman GR.

    Am J Reprod Immunol. 2003 Dec;50(6):463-72.PMID: 14750553 [PubMed - indexed for MEDLINE]Related articles

    10.

    Human immunodeficiency virus type 1 infection of human uterine epithelial cells: viral shedding and cell contact-mediated infectivity.

    Asin SN, Wildt-Perinic D, Mason SI, Howell AL, Wira CR, Fanger MW.

    J Infect Dis. 2003 May 15;187(10):1522-33. Epub 2003 Apr 23.PMID: 12721932 [PubMed - indexed for MEDLINE]Related articles

    11.

    Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection.

    Yeaman GR, Howell AL, Weldon S, Demian DJ, Collins JE, O'Connell DM, Asin SN, Wira CR, Fanger MW.

    Immunology. 2003 May;109(1):137-46.PMID: 12709027 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Receptor modulation by Fc gamma RI-specific fusion proteins is dependent on receptor number and modified by IgG.

    Guyre CA, Keler T, Swink SL, Vitale LA, Graziano RF, Fanger MW.

    J Immunol. 2001 Dec 1;167(11):6303-11.PMID: 11714794 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    CD8+ T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking.

    Yeaman GR, Collins JE, Fanger MW, Wira CR, Lydyard PM.

    Immunology. 2001 Apr;102(4):434-40. Erratum in: Immunology 2001 Jul;103(3):399. PMID: 11328377 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I.

    Wallace PK, Tsang KY, Goldstein J, Correale P, Jarry TM, Schlom J, Guyre PM, Ernstoff MS, Fanger MW.

    J Immunol Methods. 2001 Feb 1;248(1-2):183-94.PMID: 11223078 [PubMed - indexed for MEDLINE]Related articles

    15.

    Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo.

    Wallace PK, Kaufman PA, Lewis LD, Keler T, Givan AL, Fisher JL, Waugh MG, Wahner AE, Guyre PM, Fanger MW, Ernstoff MS.

    J Immunol Methods. 2001 Feb 1;248(1-2):167-82.PMID: 11223077 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu.

    Lewis LD, Cole BF, Wallace PK, Fisher JL, Waugh M, Guyre PM, Fanger MW, Curnow RT, Kaufman PA, Ernstoff MS.

    J Immunol Methods. 2001 Feb 1;248(1-2):149-65.PMID: 11223076 [PubMed - indexed for MEDLINE]Related articles

    17.

    Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu.

    Schwaab T, Lewis LD, Cole BF, Deo Y, Fanger MW, Wallace P, Guyre PM, Kaufman PA, Heaney JA, Schned AR, Harris RD, Ernstoff MS.

    J Immunother. 2001 Jan-Feb;24(1):79-87.PMID: 11211151 [PubMed - indexed for MEDLINE]Related articles

    18.

    Colocalization of Fc gamma RI-targeted antigen with class I MHC: implications for antigen processing.

    Guyre CA, Barreda ME, Swink SL, Fanger MW.

    J Immunol. 2001 Feb 15;166(4):2469-78.PMID: 11160307 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcgammaRI and the epidermal growth factor receptor.

    Wallace PK, Romet-Lemonne JL, Chokri M, Kasper LH, Fanger MW, Fadul CE.

    Cancer Immunol Immunother. 2000 Nov;49(9):493-503.PMID: 11092616 [PubMed - indexed for MEDLINE]Related articles

    20.

    Macrophage-targeted killing and vaccines.

    Guyre CA, Fanger MW.

    Res Immunol. 1998 Sep-Oct;149(7-8):655-60. Review. No abstract available. PMID: 9851519 [PubMed - indexed for MEDLINE]Related articles

    21.

    IFN-gamma is produced by polymorphonuclear neutrophils in human uterine endometrium and by cultured peripheral blood polymorphonuclear neutrophils.

    Yeaman GR, Collins JE, Currie JK, Guyre PM, Wira CR, Fanger MW.

    J Immunol. 1998 May 15;160(10):5145-53.PMID: 9590267 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Fc gamma RI blockade and modulation for immunotherapy.

    Wallace PK, Keler T, Guyre PM, Fanger MW.

    Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):137-41.PMID: 9435857 [PubMed - indexed for MEDLINE]Related articles

    23.

    Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells.

    Keler T, Graziano RF, Mandal A, Wallace PK, Fisher J, Guyre PM, Fanger MW, Deo YM.

    Cancer Res. 1997 Sep 15;57(18):4008-14.PMID: 9307286 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcgammaRI), blocks phagocytosis, and modulates receptor expression.

    Wallace PK, Keler T, Coleman K, Fisher J, Vitale L, Graziano RF, Guyre PM, Fanger MW.

    J Leukoc Biol. 1997 Oct;62(4):469-79.PMID: 9335317 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract.

    Howell AL, Edkins RD, Rier SE, Yeaman GR, Stern JE, Fanger MW, Wira CR.

    J Virol. 1997 May;71(5):3498-506.PMID: 9094621 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium.

    Yeaman GR, Guyre PM, Fanger MW, Collins JE, White HD, Rathbun W, Orndorff KA, Gonzalez J, Stern JE, Wira CR.

    J Leukoc Biol. 1997 Apr;61(4):427-35.PMID: 9103229 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    HIV-1-infected monocytes and monocyte-derived macrophages are impaired in their ability to produce superoxide radicals.

    Howell AL, Groveman DS, Wallace PK, Fanger MW.

    Int J Clin Lab Res. 1997;27(2):111-7.PMID: 9266281 [PubMed - indexed for MEDLINE]Related articles

    28.

    Bispecific-armed, interferon gamma-primed macrophage-mediated phagocytosis of malignant non-Hodgkin's lymphoma.

    Ely P, Wallace PK, Givan AL, Graziano RF, Guyre PM, Fanger MW.

    Blood. 1996 May 1;87(9):3813-21.PMID: 8611707 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Monoclonal antibody 197 (anti-Fc gamma RI) infusion in a patient with immune thrombocytopenia purpura (ITP) results in down-modulation of Fc gamma RI on circulating monocytes.

    Ericson SG, Coleman KD, Wardwell K, Baker S, Fanger MW, Guyre PM, Ely P.

    Br J Haematol. 1996 Mar;92(3):718-24.PMID: 8616043 [PubMed - indexed for MEDLINE]Related articles

    30.

    Differential expression of Fc receptors for IgG by monocytes and granulocytes from neonates and adults.

    Maeda M, van Schie RC, Yüksel B, Greenough A, Fanger MW, Guyre PM, Lydyard PM.

    Clin Exp Immunol. 1996 Feb;103(2):343-7.PMID: 8565322 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Anti-body-dependent cellular cytotoxicity (ADCC) function of peripheral blood polymorphonuclear neutrophils (PMN) after autologous bone marrow transplantation (ABMT).

    Ericson SG, Guyre CA, Benoit NE, Meehan KR, Mills LE, Fanger MW.

    Bone Marrow Transplant. 1995 Dec;16(6):787-91.PMID: 8750271 [PubMed - indexed for MEDLINE]Related articles

    32.

    Construction and characterization of a humanized anti-gamma-Ig receptor type I (Fc gamma RI) monoclonal antibody.

    Graziano RF, Tempest PR, White P, Keler T, Deo Y, Ghebremariam H, Coleman K, Pfefferkorn LC, Fanger MW, Guyre PM.

    J Immunol. 1995 Nov 15;155(10):4996-5002.PMID: 7594506 [PubMed - indexed for MEDLINE]Related articles

    34.

    Comments on the Fourth International Conference on Bispecific Antibodies and Cellular Cytotoxicity, Duck Key, Florida, March 1-5, 1995.

    Fanger MW, Ball ED, Drakeman DL.

    J Hematother. 1995 Oct;4(5):345-9. No abstract available. PMID: 8581367 [PubMed - indexed for MEDLINE]Related articles

    36.

    Role of Fc gamma receptors in cancer and infectious disease.

    Wallace PK, Howell AL, Fanger MW.

    J Leukoc Biol. 1994 Jun;55(6):816-26. Review.PMID: 8195706 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Comparison of cytotoxic properties of neonatal and adult neutrophils and monocytes and enhancement by cytokines.

    Stiehm ER, Roberts RL, Ank BJ, Plaeger-Marshall S, Salman N, Shen L, Fanger MW.

    Clin Diagn Lab Immunol. 1994 May;1(3):342-7.PMID: 7496973 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Targeting HIV-1 to Fc gamma R on human phagocytes via bispecific antibodies reduces infectivity of HIV-1 to T cells.

    Howell AL, Guyre PM, You K, Fanger MW.

    J Leukoc Biol. 1994 Mar;55(3):385-91.PMID: 8120455 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Production and use of anti-FcR bispecific antibodies.

    Fanger MW, Graziano RF, Guyre PM.

    Immunomethods. 1994 Feb;4(1):72-81. Review.PMID: 8069530 [PubMed - indexed for MEDLINE]Related articles

    41.

    Neuraminidase augments Fc gamma receptor II-mediated antibody-dependent enhancement of dengue virus infection.

    Mady BJ, Kurane I, Erbe DV, Fanger MW, Ennis FA.

    J Gen Virol. 1993 May;74 ( Pt 5):839-44.PMID: 8492089 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Role of oxygen intermediates in cytotoxicity: studies in chronic granulomatous disease.

    Roberts RL, Ank BJ, Fanger MW, Shen L, Stiehm ER.

    Inflammation. 1993 Feb;17(1):77-92.PMID: 8432564 [PubMed - indexed for MEDLINE]Related articles

    43.

    Use of bispecific antibodies in the therapy of tumors.

    Fanger MW, Morganelli PM, Guyre PM.

    Cancer Treat Res. 1993;68:181-94. Review.PMID: 8105851 [PubMed - indexed for MEDLINE]Related articles

    44.

    Redirected targeting of LDL to human monocyte Fc gamma receptors with bispecific antibodies.

    Morganelli PM, Kitzmiller TJ, Hemmer R, Fanger MW.

    Arterioscler Thromb. 1992 Oct;12(10):1131-8.PMID: 1390585 [PubMed - indexed for MEDLINE]Related articles

    45.

    Bispecific antibodies.

    Fanger MW, Morganelli PM, Guyre PM.

    Crit Rev Immunol. 1992;12(3-4):101-24. Review.PMID: 1476620 [PubMed - indexed for MEDLINE]Related articles

    47.

    Fc gamma receptors in cancer and infectious disease.

    Fanger MW, Erbe DV.

    Immunol Res. 1992;11(3-4):203-16. Review.PMID: 1287116 [PubMed - indexed for MEDLINE]Related articles

    49.

    Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors.

    Mady BJ, Erbe DV, Kurane I, Fanger MW, Ennis FA.

    J Immunol. 1991 Nov 1;147(9):3139-44.PMID: 1680925 [PubMed - indexed for MEDLINE]Related articles

    50.

    Bispecific antibodies for targeted cellular cytotoxicity.

    Fanger MW, Guyre PM.

    Trends Biotechnol. 1991 Nov;9(11):375-80. Review.PMID: 1367846 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...